Short-term responses of the kidney to high altitude in mountain climbers

Nephrology Dialysis Transplantation

Volumn 29, Issue 3, 2014, Pages 497-506

  Goldfarb Rumyantzev, Alexander S ^a,b   Alper, Seth L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Acclimatization; Altitude; Kidney; Mountain sickness; Physiology

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; ADRENOMEDULLIN; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; ENDOTHELIN; ENDOTHELIN 1; NATRIURETIC FACTOR; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR; RENIN; STEROID; VASOPRESSIN;

ACID BASE BALANCE; ADAPTATION; ALTITUDE; ALTITUDE DISEASE; CLINICAL FEATURE; DEHYDRATION; DISEASE PREDISPOSITION; DIURETIC ACTIVITY; ELECTROLYTE BALANCE; FLUID INTAKE; HEREDITY; HIGH ALTITUDE CEREBRAL EDEMA; HIGH ALTITUDE PULMONARY EDEMA; HUMAN; HYPOVOLEMIA; HYPOXIA; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY FUNCTION; LUNG VENTILATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN URINE LEVEL; REVIEW; ACCLIMATIZATION; ALTITUDE SICKNESS; ANOXIA; BLOOD VOLUME; BREATHING; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ACCLIMATIZATION; ACID-BASE EQUILIBRIUM; ALDOSTERONE; ALTITUDE; ALTITUDE SICKNESS; ANOXIA; BLOOD VOLUME; HUMANS; KIDNEY; NOREPINEPHRINE; RENIN; RESPIRATION; WATER-ELECTROLYTE BALANCE;

EID: 84888614981     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft051     Document Type: Review

References (115)

1. Climbing Mt. Everest is work for Supermen. New York Times, 18 March 1924
2. Shrestha M. Four die on Mount Everest. CNN News, 21 May 2012. http://articles.cnn.com/2012-05-21/asia/world-asia-everestdeaths- 1-nepali-altitude-sickness-mountaineers-s=PM:ASIA (25 May 2012, date last accessed)
3. Wang SS. What Everest teaches about disease. The Wall Street J (Health andWellness Section), 29 May 2012, D3
4. Davis W. Into the Silence: The Great War, Mallory, and the Conquest of Everest, 1st edn. New York: Alfred A. Knopf, 2011
5. Isserman M, Weaver SA, Molenaar D. Fallen Giants: A History of Himalayan Mountaineering from the Age of Empire to the Age of Extremes. New Haven, CT: Yale University Press, 2008
6. Krakauer J. Into Thin Air: A Personal Account of the Mount Everest Disaster, 1st edn. New York: Villard, 1997
7. West JB. Human responses to extreme altitudes. Integr Comp Biol 2006; 46: 25-34
8. Paralikar SJ, Paralikar JH. High-altitude medicine. Indian J Occup Environ Med 2010; 14: 6-12
9. Gonzales GF. Peruvian contributions to the study on human reproduction at high altitude: from the chronicles of the Spanish conquest to the present. Respir Physiol Neurobiol 2007; 158: 172-179
10. Pugh LG. Physiological and medical aspects of the Himalayan scientific and mountaineering expedition, 1960-61. Br Med J 1962; 2: 621-627
11. West JB. Human physiology at extreme altitudes on Mount Everest. Science 1984; 223: 784-788
12. Haditsch B, Roessler A, Hinghofer-Szalkay HG. Renal adrenomedullin and high altitude diuresis. Physiol Res 2007; 56: 779-787
13. Benso A, Broglio F, Aimaretti G et al. Endocrine and metabolic responses to extreme altitude and physical exercise in climbers. Eur J Endocrinol 2007; 157: 733-740
14. Houston CS, Sutton JR, Cymerman A et al. Operation Everest II: man at extreme altitude. J Appl Physiol 1987; 63: 877-882
15. Richalet JP, Robach P, Jarrot S et al. Operation Everest III (COMEX '97). Effects of prolonged and progressive hypoxia on humans during a simulated ascent to 8,848 M in a hypobaric chamber. Adv Exp Med Biol 1999; 474: 297-317
16. Robach P, Dechaux M, Jarrot S et al. Operation Everest III: role of plasma volume expansion on VO(2)(max) during prolonged high-altitude exposure. J Appl Physiol 2000; 89: 29-37
17. Croughs M, Van Gompel A, Van den Ende J. Acute mountain sickness in travelers who consulted a pre-travel clinic. J Travel Med 2011; 18: 337-343
18. Arestegui AH, Fuquay R, Sirota J et al. High altitude renal syndrome (HARS). J Am Soc Nephrol 2011; 22: 1963-1968
19. Jefferson JA, Escudero E, Hurtado ME et al. Hyperuricemia, hypertension, and proteinuria associated with high-altitude polycythemia. Am J Kidney Dis 2002; 39: 1135-1142
20. Roach R, Bartsch P, Hackett P et al. The Lake Louise acute mountain sickness scoring system. In: Sutton J, Houston C, Coates G (eds). Hypoxia and Molecular Medicine. Queen City, Burlington, VT, 1993; 272-274
21. Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001; 345: 107-114
22. Julian CG, Subudhi AW, Wilson MJ et al. Acute mountain sickness, inflammation, and permeability: new insights from a blood biomarker study. J Appl Physiol 2011; 111: 392-399
23. Tissot van Patot MC, Leadbetter G, Keyes LE et al. Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness. J Appl Physiol 2005; 98: 1626-1629
24. Nilles E, Sayward H, D'Onofrio G. Vascular endothelial growth factor and acute mountain sickness. J Emerg Trauma Shock 2009; 2: 6-9
25. Dorward DA, Thompson AA, Baillie JK et al. Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness. Respir Med 2007; 101: 587-594
26. Walter R, Maggiorini M, Scherrer U et al. Effects of high-altitude exposure on vascular endothelial growth factor levels in man. Eur J Appl Physiol 2001; 85: 113-117
27. Schommer K, Wiesegart N, Dehnert C et al. No correlation between plasma levels of vascular endothelial growth factor or its soluble receptor and acute mountain sickness. High Alt Med Biol 2011; 12: 323-327
28. Maggiorini M. Prevention and treatment of high-altitude pulmonary edema. Prog Cardiovasc Dis 2010; 52: 500-506
29. Maggiorini M, Brunner-La Rocca HP, Peth S et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 2006; 145: 497-506
30. Basnyat B, Murdoch DR. High-altitude illness. Lancet 2003; 361: 1967-1974
31. Hopkins SR, Garg J, Bolar DS et al. Pulmonary blood flow heterogeneity during hypoxia and high-altitude pulmonary edema. Am J Respir Crit Care Med 2005; 171: 83-87
32. Bernardi L, Schneider A, Pomidori L et al. Hypoxic ventilatory response in successful extreme altitude climbers. Eur Respir J 2006; 27: 165-171
33. Buttigieg J, Pan J, Yeger H et al. NOX2 (gp91phox) is a predominant O2 sensor in a human airway chemoreceptor cell line: biochemical, molecular, and electrophysiological evidence. Am J Physiol Lung Cell Mol Physiol 2012; 303: L598-L607
34. Koeppen M, Eckle T, Eltzschig HK. The hypoxia-inflammation link and potential drug targets. Curr Opin Anaesthesiol 2011; 24: 363-369
35. Greer SN, Metcalf JL, Wang Y et al. The updated biology of hypoxia-inducible factor. EMBO J 2012; 31: 2448-2460
36. Mizuno M, Savard GK, Areskog NH et al. Skeletal muscle adaptations to prolonged exposure to extreme altitude: a role of physical activity?. High Alt Med Biol 2008; 9: 311-317
37. Huang QY, Gao YQ, Shi JQ. Changes of capillarity and blood flow of skeletal muscle in rat during acclimatization to hypoxia. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2001; 17: 220-223
38. Mancinelli R, Pietrangelo T, La Rovere R et al. Cellular and molecular responses of human skeletal muscle exposed to hypoxic environment. J Biol Regul Homeost Agents 2011; 25: 635-645
39. Yalcin O, Cabrales P. Increased hemoglobin O2 affinity protects during acute hypoxia. Am J Physiol Heart Circ Physiol 2012; 303: H271-H281
40. Hebbel RP, Eaton JW, Kronenberg RS et al. Human llamas: adaptation to altitude in subjects with high hemoglobin oxygen affinity. J Clin Invest 1978; 62: 593-600
41. Levett DZ, Radford EJ, Menassa DA et al. Acclimatization of skeletal muscle mitochondria to high-altitude hypoxia during an ascent of Everest. FASEB J 2011; 26: 1431-1441
42. Jacobs RA, Siebenmann C, Hug M et al. Twenty-eight days at 3454-m altitude diminishes respiratory capacity but enhances efficiency in human skeletal muscle mitochondria. FASEB J 2012; 26: 5192-5200
43. Jacobs RA, Boushl R, Wright-Paradis C et al. Mitochondrial function in human skeletal muscle following high altitude exposure. Exp Physiol 2012; 98: 244-255
44. Erzurum SC, Ghosh S, Janocha AJ et al. Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc Natl Acad Sci USA 2007; 104: 17593-17598
45. Becker EL, Schilling JA, Harvey RB. Renal function in man acclimatized to high altitude. J Appl Physiol 1957; 10: 79-80
46. Lozano R, Monge C. Renal function in high-altitude natives and in natives with chronic mountain sickness. J Appl Physiol 1965; 20: 1026-1027
47. Naeye RL. Children at high altitude: pulmonary and renal abnormalities. Circ Res 1965; 16: 33-38
48. Olsen NV, Kanstrup IL, Richalet JP et al. Effects of acute hypoxia on renal and endocrine function at rest and during graded exercise in hydrated subjects. J Appl Physiol 1992; 73: 2036-2043
49. Swenson ER. Renal disease and high altitude, 2007. http://www. worldcongress2007.org.uk/images/Renal%20disease%20and%20high% 20altitude%20-%20Erik%20Swenson.pdf (27 November 2011, date last accessed)
50. Bestle MH, Olsen NV, Poulsen TD et al. Prolonged hypobaric hypoxemia attenuates vasopressin secretion and renal response to osmostimulation in men. J Appl Physiol 2002; 92: 1911-1922
51. Pichler J, Risch L, Hefti U et al. Glomerular filtration rate estimates decrease during high altitude expedition but increase with Lake Louise acute mountain sickness scores. Acta Physiol (Oxf) 2008; 192: 443-450
52. Singh MV, Salhan AK, Rawal SB et al. Blood gases, hematology, and renal blood flow during prolonged mountain sojourns at 3500 and 5800 m. Aviat Space Environ Med 2003; 74: 533-536
53. Khan DA, Aslam M, Khan ZU. Changes in plasma electrolytes during acclimatization at high altitude. J Pak Med Assoc 1996; 46: 128-131
54. Winslow RM, Samaja M, West JB. Red cell function at extreme altitude on Mount Everest. J Appl Physiol 1984; 56: 109-116
55. Grocott MP, Martin DS, Levett DZ et al. Arterial blood gases and oxygen content in climbers on Mount Everest. N Engl J Med 2009; 360: 140-149
56. Ge RL, Babb TG, Sivieri M et al. Urine acid-base compensation at simulated moderate altitude. High Alt Med Biol 2006; 7: 64-71
57. Zubieta-Calleja G, Zubieta-Castillo G, Zubieta-Calleja L. et al. Do over 200 million healthy altitude residents really suffer from chronic Acidbase disorders?. Indian J Clin Biochem 2012; 26: 62-65
58. Krapf R, Beeler I, Hertner D et al. Chronic respiratory alkalosis. The effect of sustained hyperventilation on renal regulation of acid-base equilibrium. N Engl J Med 1991; 324: 1394-1401
59. Jones RM, Terhaard C, Zullo J et al. Mechanism of reduced water intake in rats at high altitude. Am J Physiol 1981; 240: R187-R191
60. Westerterp KR, Meijer EP, Rubbens M et al. Operation Everest III: energy and water balance. Pflugers Arch 2000; 439: 483-488
61. Jain SC, Bardhan J, Swamy YV et al. Body fluid compartments in humans during acute high-altitude exposure. Aviat Space Environ Med 1980; 51: 234-236
62. Heyes MP, Farber MO, Manfredi F et al. Acute effects of hypoxia on renal and endocrine function in normal humans. Am J Physiol 1982; 243: R265-R270
63. Hildebrandt W, Ottenbacher A, Schuster M et al. Diuretic effect of hypoxia, hypocapnia, and hyperpnea in humans: relation to hormones and O2 chemosensitivity. J Appl Physiol 2000; 88: 599-610
64. Koller EA, Buhrer A, Felder L et al. Altitude diuresis: endocrine and renal responses to acute hypoxia of acclimatized and non-acclimatized subjects. Eur J Appl Physiol Occup Physiol 1991; 62: 228-234
65. Swenson ER, Duncan TB, Goldberg SV et al. Diuretic effect of acute hypoxia in humans: relationship to hypoxic ventilatory responsiveness and renal hormones. J Appl Physiol 1995; 78: 377-383
66. Bartsch P, Shaw S, Franciolli M et al. Atrial natriuretic peptide in acute mountain sickness. J Appl Physiol 1988; 65: 1929-1937
67. Mazzeo RS, Brooks GA, Butterfield GE et al. Acclimatization to high altitude increase muscle sympathetic activity both at rest and during exercise. Am J Physiol 1995; 269: R201-R207
68. Brezis M, Heyman SN, Epstein FH. Determinants of intrarenal oxygenation. II. Hemodynamic effects. Am J Physiol 1994; 267: F1063-F1068
69. Epstein FH, Agmon Y, Brezis M. Physiology of renal hypoxia. Ann N Y Acad Sci 1994; 718: 72-81; discussion 81-82
70. Claybaugh JR, Hansen JE, Wozniak DB. Response of antidiuretic hormone to acute exposure to mild and severe hypoxia in man. J Endocrinol 1978; 77: 157-160
71. Ramirez G, Hammond M, Agosti SJ et al. Effects of hypoxemia at sea level and high altitude on sodium excretion and hormonal levels. Aviat Space Environ Med 1992; 63: 891-898
72. Honig A. Peripheral arterial chemoreceptors and reflex control of sodium and water homeostasis. Am J Physiol 1989; 257: R1282-R1302
73. Buskirk ER, Puhl SM. Body Fluid Balance: Exercise and Sport (Nutrition in Exercise & Sport). Boca Raton; Boston; London; New York; Washington, DC: CRC Press, 1996
74. Modesti PA, Vanni S, Morabito M et al. Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study. Circulation 2006; 114: 1410-1416
75. Staubli M, Rohner F, Kammer P et al. Plasma volume and proteins in voluntary hyperventilation. J Appl Physiol 1986; 60: 1549-1553
76. Steurer J, Schiesser D, Stey C et al. Hyperventilation enhances transcapillary diffusion of sodium fluorescein. Int J Microcirc Clin Exp 1996; 16: 266-270
77. Gledhill N, Beirne GJ, Dempsey JA. Renal response to short-term hypocapnia in man. Kidney Int 1975; 8: 376-384
78. Zaccaria M, Rocco S, Noventa D et al. Sodium regulating hormones at high altitude: basal and post-exercise levels. J Clin Endocrinol Metab 1998; 83: 570-574
79. Woods D, Hooper T, Hodkinson P et al. Effects of altitude exposure on brain natriuretic peptide in humans. Eur J Appl Physiol 2011; 111: 2687-2693
80. Loeppky JA, Icenogle MV, Maes D et al. Early fluid retention and severe acute mountain sickness. J Appl Physiol 2005; 98: 591-597
81. Maresh CM, Kraemer WJ, Judelson DA et al. Effects of high altitude and water deprivation on arginine vasopressin release in men. Am J Physiol Endocrinol Metab 2004; 286: E20-E24
82. Bartsch P, Maggiorini M, Schobersberger W et al. Enhanced exerciseinduced rise of aldosterone and vasopressin preceding mountain sickness. J Appl Physiol 1991; 71: 136-143
83. Bartsch P, Pfluger N, Audetat M et al. Effects of slow ascent to 4559 m on fluid homeostasis. Aviat Space Environ Med 1991; 62: 105-110
84. Kojonazarov B, Isakova J, Imanov B et al. Bosentan reduces pulmonary artery pressure in high altitude residents. High Alt Med Biol 2012; 13: 217-223
85. Oishi R, Nonoguchi H, Tomita K et al. Endothelin-1 inhibits AVPstimulated osmotic water permeability in rat inner medullary collecting duct. Am J Physiol 1991; 261: F951-F956
86. Zeidel ML, Brady HR, Kone BC et al. Endothelin, a peptide inhibitor of Na+-K+-ATPase in intact renaltubular epithelial cells. Am J Physiol 1989; 257: C1101-7
87. Sato K, Hirata Y, Imai T et al. Characterization of immunoreactive adrenomedullin in human plasma and urine. Life Sci 1995; 57: 189-194
88. Nishikimi T. Adrenomedullin in the kidney-renal physiological and pathophysiological roles. Curr Med Chem 2007; 14: 1689-1699
89. Hofbauer KH, Jensen BL, Kurtz A et al. Tissue hypoxygenation activates the adrenomedullin system in vivo. Am J Physiol Regul Integr Comp Physiol 2000; 278: R513-R519
90. Nagata D, Hirata Y, Suzuki E et al. Hypoxia-induced adrenomedullin production in the kidney. Kidney Int 1999; 55: 1259-1267
91. Taylor MM, Samson WK. Adrenomedullin and the integrative physiology of fluid and electrolyte balance. Microsc Res Tech 2002; 57: 105-109
92. Jensen BL, Kramer BK, Kurtz A. Adrenomedullin stimulates renin release and renin mRNA in mouse juxtaglomerular granular cells. Hypertension 1997; 29: 1148-1155
93. Bell D, McDermott BJ. Intermedin (adrenomedullin-2): a novel counterregulatory peptide in the cardiovascular and renal systems. Br J Pharmacol 2008; 153(Suppl 1): S247-S262
94. Grover RF, Weil JV, Reeves JT. Cardiovascular adaptation to exercise at high altitude. Exerc Sport Sci Rev 1986; 14: 269-302
95. Leaf DE, Goldfarb DS. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol 2007; 102: 1313-1322
96. Anand AC, Jha SK, Saha A et al. Thrombosis as a complication of extended stay at high altitude. Natl Med J India 2001; 14: 197-201
97. Chen F, Zhang W, Liang Y et al. Transcriptome and network changes in climbers at extreme altitudes. PLoS One 2012; 7: e31645
98. Walker BR. Diuretic response to acute hypoxia in the conscious dog. Am J Physiol 1982; 243: F440-F446
99. Yi X, Liang Y, Huerta-Sanchez E et al. Sequencing of 50 human exomes reveals adaptation to high altitude. Science 2010; 329: 75-78
100. Beall CM, Cavalleri GL, Deng L et al. Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci USA 2010; 107: 11459-11464
101. Kapitsinou PP, Liu Q, Unger TL et al. Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood 2010; 116: 3039-3048
102. MacInnis MJ, Koehle MS, Rupert JL. Evidence for a genetic basis for altitude illness: 2010 update. High Alt Med Biol 2010; 11: 349-368
103. Simonson TS, McClain DA, Jorde LB et al. Genetic determinants of Tibetan high-altitude adaptation. Hum Genet 2012; 131: 527-533
104. Pagani L, Ayub Q, MacArthur DG et al. High altitude adaptation in Daghestani populations from the Caucasus. Hum Genet 2011; 131: 423-433
105. Scheinfeldt LB, Soi S, Thompson S et al. Genetic adaptation to high altitude in the Ethiopian highlands. Genome Biol 2012; 13: R1
106. Young AJ, Sawka MN, Muza SR et al. Effects of erythrocyte infusion on VO2max at high altitude. J Appl Physiol 1996; 81: 252-259
107. Kayser B, Dumont L, Lysakowski C et al. Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis. High Alt Med Biol 2012; 13: 82-92
108. Lipman GS, Kanaan NC, Holck PS et al. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories. Ann EmergMed 2012; 59: 484-490
109. Luks AM, Swenson ER. Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness. Chest 2008; 133: 744-755
110. Oelz O, Maggiorini M, Ritter M et al. Nifedipine for high altitude pulmonary oedema. Lancet 1989; 2: 1241-1244
111. Sartori C, Allemann Y, Duplain H et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002; 346: 1631-1636
112. Grissom CK, Roach RC, Sarnquist FH et al. Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med 1992; 116: 461-465
113. Basnyat B, Holck PS, Pun M et al. Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebocontrolled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group). Wilderness Environ Med 2011; 22: 15-22
114. van Patot MC, Leadbetter G, III, Keyes LE et al. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. High Alt Med Biol 2008; 9: 289-293
115. Basnyat B, Hargrove J, Holck PS et al. Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans. High Alt Med Biol 2008; 9: 209-216